New diabetes clinical trial: Pathogenesis of Uric Acid Nephrolithiasis: Role of Pioglitazone/Weight Loss

Published on: April 30, 2020 at 09:30PM
Condition:   Nephrolithiasis, Uric Acid
Interventions:   Drug: Pioglitazone 45 mg;   Behavioral: Weight Loss;   Other: Pioglitazone + Weight Loss
Sponsor:   University of Texas Southwestern Medical Center
Active, not recruiting
https://ift.tt/3d4dtk6